Posts

Making AI smarter with an artificial, multisensory inte...

The feel of a cat’s fur can reveal some information, but seeing the feline provi...

University of Kentucky Markey Cancer Center attains NCI...

The University of Kentucky Markey Cancer Center announced today that it has earn...

Brain inspires more robust AI

Most artificially intelligent systems are based on neural networks, algorithms i...

Prescribing just a few opioid tablets to patients disch...

Barcelona, Spain: Half of patients discharged from the emergency department need...

Scientists successfully grow part-human part-pig kidney...

Researchers have successfully cultivated part-human, part-pig kidneys within pig...

FDA Issues Warning to 8 Companies Selling Illegal Eye D...

The Food and Drug Administration (FDA) said on Tuesday that it is taking action ...

Signal: Danaher’s $5.7bn acquisition of Abcam faces sta...

Abcam founder Jonathan Milner has declared his intention to vote against the acq...

Cure Genetics and Frametact seek gene cures for neurolo...

Cure Genetics has entered a partnership and licensing deal with Frametact to dev...

Market cap rebound by top 20 biopharmaceutical companie...

Market capitalisation increased by a total of 2.3% from $3.49tn in Q1 2023 to $3...

Generate:Biomedicines secures $273m to advance therapeu...

Generate:Biomedicines has secured $273m in Series C financing round to expedite ...

No more cookies: How healthcare companies can gain trus...

Healthcare and life sciences companies have long relied on third-party cookies f...

SparingVision shares trial updates for rare eye disease...

The company is also planning to expand its Phase I/II PRODYGY lead candidate tri...

NICE recommends Idorsia’s chronic insomnia treatment fo...

The therapy will be available to patients who have insomnia multiple times a wee...

Remote Patient Monitoring market will reach $760m by 2030

A new report found that the Remote Patient Monitoring (RPM) sector will grow, si...

Iovance’s PDUFA date for lifileucel pushed due to FDA b...

The FDA pushed lifileucel’s PDUFA date from November this year to 24 February 20...

argenx wins EMA CHMP nod for subcutaneous Vyvgart in my...

The positive opinion relied on a comparator study that showed the subcutaneous v...